Abstract:Over the last decade, hydrogen sulfide (H2S) has emerged as an important endogenous gasotransmitter in mammalian cells and tissues. Similar to the previously characterized gasotransmitters nitric oxide and carbon monoxide, H2S is produced by various enzymatic reactions and regulates a host of physiologic and pathophysiological processes in various cells and tissues. H2S levels are decreased in a number of conditions (e.g., diabetes mellitus, ischemia, and aging) and are increased in other states (e.g., inflammation, critical illness, and cancer). Over the last decades, multiple approaches have been identified for the therapeutic exploitation of H2S, either based on H2S donation or inhibition of H2S biosynthesis. H2S donation can be achieved through the inhalation of H2S gas and/or the parenteral or enteral administration of so-called fast-releasing H2S donors (salts of H2S such as NaHS and Na2S) or slow-releasing H2S donors (GYY4137 being the prototypical compound used in hundreds of studies in vitro and in vivo). Recent work also identifies various donors with regulated H2S release profiles, including oxidant-triggered donors, pH-dependent donors, esterase-activated donors, and organelle-targeted (e.g., mitochondrial) compounds. There are also approaches where existing, clinically approved drugs of various classes (e.g., nonsteroidal anti-inflammatories) are coupled with H2S-donating groups (the most advanced compound in clinical trials is ATB-346, an H2S-donating derivative of the non-steroidal anti-inflammatory compound naproxen). For pharmacological inhibition of H2S synthesis, there are now several small molecule compounds targeting each of the three H2S-producing enzymes cystathionine-β-synthase (CBS), cystathionine-γ-lyase, and 3-mercaptopyruvate sulfurtransferase. Although many of these compounds have their limitations (potency, selectivity), these molecules, especially in combination with genetic approaches, can be instrumental for the delineation of the biologic processes involving endogenous H2S production. Moreover, some of these compounds (e.g., cell-permeable prodrugs of the CBS inhibitor aminooxyacetate, or benserazide, a potentially repurposable CBS inhibitor) may serve as starting points for future clinical translation. The present article overviews the currently known H2S donors and H2S biosynthesis inhibitors, delineates their mode of action, and offers examples for their biologic effects and potential therapeutic utility.

Bad Smells and Broken DNA: A Tale of Sulfur-Nucleic Acid Cooperation

Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis

Molecular Functions of Hydrogen Sulfide in Cancer

Hydrogen Sulfide in Biochemistry and Medicine

Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells

H(2)S and Cellular Proliferation and Apoptosis.

Hydrogen Sulfide Biology and Its Role in Cancer

Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter

Gasping for Sulfide: A Critical Appraisal of Hydrogen Sulfide in Lung Disease and Accelerated Aging

S-Sulfhydration of Mek1 Leads to Parp-1 Activation and Dna Damage Repair

Endogenous production and physiological functions of hydrogen sulfide in facultative anaerobic bacteria

Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics

Hydrogen sulfide as an endogenous modulator in mitochondria and mitochondria dysfunction.

Generation and Physiology of Hydrogen Sulfide and Reactive Sulfur Species in Bacteria

Biophysical characterization of hydrogen sulfide: A fundamental exploration in understanding significance in cell signaling

Signaling molecules: hydrogen sulfide and polysulfide

H2S: A Simple Molecule with Multifaceted Biochemistry and Functions

A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

H2S-Induced Sulfhydration: Biological Function and Detection Methodology

International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors

Hydrogen Sulfide: Biogenesis, Physiology, and Pathology